Over 100 years serving the Lord home and around the world
First Baptist Church
We are a church who's members come from many nations of origin to worship together!


From December 25 and has moved its decision day.

Bristol-Myers extends period to review BLA for ipilimumab in melanoma Bristol-Myers Squibb Business today announced that the U.S. Food and Drug Administration has motivated that additional time must complete the overview of the biologics permit program for ipilimumab in pre-treated advanced melanoma, from December 25 and has moved its decision day, 2010 to March 26, 2011. Related StoriesOncolytic viral therapy accepted in the U.S. For make use of against late-stage melanomaDiscovery may open new doors to understanding how melanoma grows and spreadsStudy talks about survival benefits of medical resection for melanoma sufferers with abdominal metastasesIn response to an FDA request, Bristol-Myers Squibb submitted further evaluation of data pertaining to the existing application for pre-treated advanced melanoma and the agency considers this to be a main amendment to the drug’s BLA. Continue reading

Avalon Ventures.

Each will obtain up to $10 million in Series A funding and R&D support from Avalon Ventures and GSK. Both ongoing businesses will become located at COI Pharmaceuticals in NORTH PARK, the grouped community of invention founded by Avalon Ventures to supply operational support, a completely equipped R&D service and a skilled leadership group to its life technology portfolio businesses. Our collaboration with GSK represents a fresh model for generating early-stage medication discovery, stated Jay Lichter, Ph.D., controlling director of Avalon Ventures. By merging the nimble start-up mentality of Avalon with the unmatched R&D expertise and sources of a global pharmaceutical huge like GSK, in under 18 months we’ve launched three new businesses in varied therapeutic areas and finished our initial compound screen for medication applicant identification in a robust collaboration with GSK. Continue reading

Circumcision tied to lower prostate cancer risk To circumcise or never to circumcise?

‘These data are consistent with an infectious/inflammatory pathway which may be involved in the threat of prostate cancer in a few men,’ study author Dr. Jonathan Wright, assistant professor of urology at the University of Washington School of Medication, said in a written statement. ‘Although observational only, these data recommend a biologically plausible mechanism by which circumcision may reduce the risk of prostate cancer. Future research of this relationship is warranted.’ Should all men be circumcised to lessen their prostate cancer risk? ‘At the end of the day, we experience there’s dangers and benefits, and it’s up to the parents to choose what is in the best interests of their child,’ Dr. Continue reading

AltraVax acquires vaccine advancement technology package from Maxygen AltraVax.

Dr. Whalen. Leonard Ruiz, who has 30 years of international and domestic experience in the biotechnology, biopharmaceutical and food sectors, acts as CEO of AltraVax. Ruiz. 5 years. Brighton Hospital, the Addiction Treatment Center of Excellence within Ascension Health, the biggest US faith-based health system, was selected after a nine-month international search that included several other larger and more well-known addiction treatment hospitals in the U.S., Asia and Europe.’ According to Denise Bertin-Epp, President and Chief Nursing Officer of Brighton Hospital, another deciding aspect for Al-Turaiki was Brighton Hospital’s proprietary electronic behavioral health record technology, developed with New Jersey-centered Medical Communication Systems. Continue reading

The business is also donating yet another $2.

Moulton donated her winnings to St. Joseph's Hospice to greatly help in the delivery of end of bereavement and existence providers in the Sarnia Lambton region. ‘Palliative care is a thing that almost every among us will require,’ adds Bayshore Home Wellness's Quinn. ‘We are encouraging everyone – including doctors, hospital staff, public workers, discharge planners, various other healthcare professionals and the general public – to go surfing and enter the contest so the earning hospice can move nearer to its fundraising goals.’.. Bayshore Home Wellness joins Hike for Hospice Palliative Treatment fundraiser for eighth consecutive year Invites Canadians to enter online Hospice Donation Pull that may award winning community hospice $2,000 Bayshore Home Health is getting into its eighth consecutive 12 months to improve money for neighborhood palliative care hospices in the united states. Continue reading

According to a written report published online by JAMA Face COSMETIC SURGERY.

Autologous rib cartilage use in rhinoplasty connected with low rates of general long-term complications Using a individual's have rib cartilage for rhinoplasty is apparently associated with low prices of general long-term complications and complications in the rib site where in fact the cartilage is certainly removed, according to a written report published online by JAMA Face COSMETIC SURGERY finast i vietnam . Autologous rib cartilage may be the preferred way to obtain graft materials for rhinoplasty due to its strength and enough volume. Nevertheless, using rib cartilage for dorsal augmentation to develop the bridge of the nasal area has been criticized because of its inclination to warp and problems at the cartilage donor site, such as for example pneumothorax and postoperative scarring. Continue reading

Around the knuckle.

Preclinical screening was performed at CV Route Institute and validated that Cardionovum’s DEB coating does not trigger any noticeable micro-emboli, which classifies Cardionovum’s DEBs to end up being as safe as any uncoated angioplasty balloon catheter relative to potential micro-embolies. Both safety features, integrity of the medication coating non-occurrence and composition of micro-emboli, increase the safety account for operators and patients and fulfill safety requirements of regulatory authorities. Related StoriesMiriam Hospital enrolling local participants for Parachute implant medical trial to take care of heart failureNew heart-powered pacemakers could be on the horizonNovel prosthetic center valve created for treatment of mitral regurgitation Cardionovum holds world-wide multiple priority patent-pending privileges for its coating technology.g., diabetic patients) and sufferers with dialysis fistula stenosis. Continue reading

The technology for doing this.

During the past, scientists grew stem cells on areas that contained mouse cells. That left scientists with nagging questions about feasible contamination of stem cells with disease-causing animal infections – a stumbling block for using stem cells in potential medical applications. And that growth program was what scientists term ‘undefined.’ There were variations from batch to batch of mouse cells, and researchers never really knew what the stem cells had been coming into contact with and how it might be changing them. The synthetic, chemically-defined, areas finished that uncertainty. The approach was inexpensive, basic and a much-needed advance in creating stem cells, Kiessling described. Related StoriesKey protein settings stem cell properties that could make them useful in regenerative medicinePublic plan needed to reduce stem cell tourism, say expertsFranziska Michor called recipient of NYSCF – Robertson Stem Cell PrizeWith the ability to develop stem cells on the artificial areas under chemically described, or known, conditions, Kiessling’s group took an additional part of their latest research. Continue reading

The research team ?sildenafil india.

Cell phone radiation breast malignancy link – New research raises grave concerns A new study raises concerns of a possible association between cell phone radiation exposure and breast cancer in young women ?sildenafil india . The research team, led by Dr. Lisa Bailey, a former president of the American Cancers Society’s California Division and among California’s top breasts surgeons, studied four young women – aged from 21 to 39 years older – with multifocal invasive breasts cancer. Continue reading